Bio-markers of disease activity and response to therapy in multiple sclerosis

被引：28
作者：
Miller, A
Glass-Marmor, L
Abraham, M
Grossman, I
Shapiro, S
Galboiz, Y
机构：
[1] Technion Israel Inst Technol, Fac Med, Div Neuroimmunol, IL-34362 Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Rappaport Inst Res Med Sci, Carmel Med Ctr,Multiple Sclerosis Ctr, IL-34362 Haifa, Israel
来源：
CLINICAL NEUROLOGY AND NEUROSURGERY | 2004年 / 106卷 / 03期
关键词：
antibody; bio-marker; cytokine; MMP; multiple sclerosis;
D O I：
10.1016/j.clineuro.2004.02.008
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：249 / 254
页数：6
相关论文
共 76 条
[1]   The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system [J].
Anderson, DE ;
Sharpe, AH ;
Hafler, DA .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :677-683
[2]   Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke [J].
Anthony, DC ;
Ferguson, B ;
Matyzak, MK ;
Miller, KM ;
Esiri, MM ;
Perry, VH .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) :406-415
[3]   Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4(+) T cells via CD40 ligand [J].
Balashov, KE ;
Smith, DR ;
Khoury, SJ ;
Hafler, DA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :599-603
[4]   Molecular pathogenesis of multiple sclerosis [J].
Bar-Or, A ;
Oliveira, EML ;
Anderson, DE ;
Hafler, DA .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :252-259
[5]   Clinical and laboratory features of primary progressive and secondary progressive MS [J].
Bashir, E ;
Whitaker, JN .
NEUROLOGY, 1999, 53 (04) :765-771
[6]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145
[7]   CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone [J].
Boylan, MT ;
Crockard, AD ;
McDonnell, GV ;
Armstrong, MA ;
Hawkins, SA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 167 (02) :79-89
[8]   p-Cresol sulfate is the dominant component of urinary myelin basic protein like material [J].
Cao, LG ;
Kirk, MC ;
Coward, LU ;
Jackson, P ;
Whitaker, JN .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 377 (01) :9-21
[9]  
CAWSTON T, 1998, MOL MED TODAY, V3, P130
[10]  
Comi G, 1999, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, P19
12345678